CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 38 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,111,000 | -18.8% | 90,259 | 0.0% | 0.00% | – |
| Q4 2020 | $2,599,000 | -67.5% | 90,259 | -77.1% | 0.00% | -100.0% |
| Q3 2020 | $7,998,000 | -62.4% | 394,764 | -44.3% | 0.00% | -50.0% |
| Q2 2020 | $21,283,000 | -49.3% | 708,257 | -46.9% | 0.00% | -66.7% |
| Q1 2020 | $41,952,000 | -43.7% | 1,334,764 | -15.6% | 0.01% | -25.0% |
| Q4 2019 | $74,515,000 | +915.9% | 1,581,715 | +39.3% | 0.01% | +700.0% |
| Q3 2019 | $7,335,000 | -56.5% | 1,135,387 | -17.4% | 0.00% | -50.0% |
| Q2 2019 | $16,878,000 | -20.9% | 1,374,464 | -12.7% | 0.00% | -33.3% |
| Q1 2019 | $21,331,000 | +247.9% | 1,574,245 | -0.0% | 0.00% | +200.0% |
| Q4 2018 | $6,131,000 | -40.4% | 1,574,445 | -2.7% | 0.00% | 0.0% |
| Q3 2018 | $10,281,000 | – | 1,618,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |